Marketing Practices of Pharma Industry in Telangana

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

MARKETING PRACTICES OF PHARMA INDUSTRY IN TELANGANA

Jatoth Geetha*

Affiliations
*
Independent Researcher, Siddharth Engineering College & Technology, Osmania University, Hyderabad- 500007,
Telangana, India.

ABSTRACT

Every individual suffers with some diseases or the other. Drugs and medicines become important
supplements of many lives. This has led to the emergence and rapid development of the pharmaceutical
sector. The emergence of a particular disease has led to the emergence of a specific drug. Marketing such
drugs and staying in the competition has become a challenge to the pharmaceutical companies. In order to
sustain themselves in the competitive world, pharmaceutical companies have started using different
marketing strategies like direct and indirect methods. The present study evaluates the present scenario of
the marketing practices being followed by the pharmaceutical companies and how they are affecting the
sale of drugs.

KEYWORDS
Marketing Practices; Pharmaceuticals; Sales; Telangana

JEL CLASSIFICATION
I1, M3, M4, Y1, Z0

REFRENCES
Arun Kumar, v. Shekhar. (2014) A study on employee retention in the pharmaceutical sector in city of
pearls, Asian academic research journal of social sciences& humanities. 1 (22) 174-190.

Arun Kumar, Morthati Kishore, DR.Y. Jahangir (2015).A Study on Talent Management Practices in
Pharmaceutical sector in Telangana. Jamshedpur Research Review. 2 (9).31-40.

Ashley Wazana. (2000)Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?. Journal of
the American Medical Association. 283 (2): 373–380.

Cegedim Strategic Data, 2012 U.S. Pharmaceutical Company Promotion Spending (2013).

Charles Ornstein, Tracy Weber, and Dan Nguyen(2011). Piercing the Veil, More Drug Companies Reveal
Payments to Doctors. ProPublica.

Charles Ornstein(2011). Doctors Dine on Drug Companies' Dime,” ProPublica.Ibid.


C.G. Alexander, J. Zhang, and A. Basu. (2008) “Characteristics of Patients Receiving Pharmaceutical
Samples and Association Between Sample Receipt and Out-of-Pocket Prescription Costs,” Medical
Care 46 (8): 394–402.

C. Wick et al.,(2007). The Characteristics of Unsolicited Clinical Oncology Literature Provided by


Pharmaceutical Industry. Annals of Oncology .18 (2): 1580–82.

Food and Drug Administration Division of Drug Marketing, Advertising, and Communications, letters to
Biogen Idec, Sanofi Aventis U.S., Bayer HealthCare Pharmaceuticals, GlaxoSmithKline, Forest
Laboratories Inc., Cephalon Inc., Johnson & Johnson Pharmaceutical Services, Pfizer Inc., Novartis
Pharmaceuticals Corp., Genentech Inc., Boehringer Ingelheim Pharmaceuticals Inc., Merck & Co.,
Hoffmann-La Roche Inc., and Eli Lilly and Co. (April 2009).

Harriet Washington (2011). Flacking for Big Pharma, Drugmakers don’t just compromise doctors; they
also undermine top medical journals and skew medical research.

Iain M. Cockburn (2004). The Changing Structure Of The Pharmaceutical Industry 10Health Affairs.
23 (1) 10-22. DoI: 10.1377/hlthaff.23.1.10.

James Rhee.(2008) The Influence of the Pharmaceutical Industry on Healthcare Practitioners’ Prescribing
Habits. The Internet Journal of Academic Physician Assistants. 7 (1).

Jonathan D. Rockoff(2012) . Drug Reps Soften Their Sales Pitches. Wall Street Journal.

Julie M. Donohue, Marisa Cevasco, and Meredith B. Rosenthal (2007). A Decade of Direct-to-Consumer
Advertising of Prescription Drugs. New England Journal of Medicine. 357. 673–81.

Morthati. Kishore, A.Arun Kumar, V. Shekhar. (2014). A study on employee retention practices in
pharmaceutical companies of northern Telangana state. International Journal of Research in
Management. 4 (1). 66-85.

M. Peyrot, N.M. Alperstein, D. Van Doren, and L.G. Poli (1998). Direct-to-Consumer Ads Can Influence
Behavior; Advertising Increases Consumer Knowledge and Prescription Drug Requests. Marketing
Health Services 18 (1). 26-32.

M.Y. Peay and E.R. Peay. (1998). The Role of Commercial Sources in the Adoption of a New Drug.
Social Science and Medicine 26 (1):1183–1189. Ibid.
Noelle C. Sitthikul (2007). Senate Finance Committee Releases Report on Drug Industry CME Grants,”
FDA Law Blog.

Robert A. Bell, Richard L. Kravitz, and Michael S. Wilkes(1999). Direct-to-Consumer Prescription Drug
Advertising and the Public,” Journal of General Internal Medicine 14 (1). 651–57.

Richard L. Kravitz et al., (2005). Influence of Patients' Requests for Direct-to-Consumer Advertised
Antidepressants: A Randomized Controlled Trial. Journal of the American Medical Association.
293 (2). 1995–2002.

FULL TEXT: PDF


SHARE: Face book, Twitter, Linked in, What’s Up, Print

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy